Published in Mar Drugs on April 14, 2015
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 13.73
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb (1994) 8.54
Nitric oxide synthases: regulation and function. Eur Heart J (2011) 4.71
Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol (2003) 3.44
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol (2001) 3.38
Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol (2007) 3.36
Endothelial dysfunction. J Am Soc Nephrol (2004) 3.18
Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res (2001) 3.18
ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb (1994) 3.11
Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem (2001) 2.56
Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol (2004) 2.37
Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension (2011) 1.97
Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A (2005) 1.93
Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation (2004) 1.56
Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension (2007) 1.48
The unfolding tale of PECAM-1. FEBS Lett (2003) 1.41
Quantitative assay for mouse atherosclerosis in the aortic root. Methods Mol Med (2006) 1.38
Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem (2001) 1.37
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care (2011) 1.37
Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat Med (2012) 1.23
Mouse models of hyperlipidemia and atherosclerosis. Front Biosci (2001) 1.20
An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E⁻/⁻ mice. Sci Rep (2014) 1.18
Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation (2010) 1.14
Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies. Clin Chim Acta (2004) 1.12
Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J Biol Chem (2002) 1.10
A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. Biochem Pharmacol (2009) 0.98
Hyperhomocysteinemia alters cardiac substrate metabolism by impairing nitric oxide bioavailability through oxidative stress. Circulation (2007) 0.98
The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Endothelium (2004) 0.97
Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells. Brain Res (2010) 0.95
Design and synthesis of novel xyloketal derivatives and their vasorelaxing activities in rat thoracic aorta and angiogenic activities in zebrafish angiogenesis screen. J Med Chem (2010) 0.94
Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide (2013) 0.94
Xyloketal B exhibits its antioxidant activity through induction of HO-1 in vascular endothelial cells and zebrafish. Mar Drugs (2013) 0.91
Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage. Brain Res (2009) 0.91
Diet-induced obesity severely impairs myelinated aortic baroreceptor reflex responses. Am J Physiol Heart Circ Physiol (2012) 0.90
Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension. Am J Physiol Heart Circ Physiol (2013) 0.89
Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol (2001) 0.89
Shear stress regulates angiotensin type 1 receptor expression in endothelial cells. Circ Res (2009) 0.88
Synthesis of xyloketal A, B, C, D, and G analogues. J Org Chem (2006) 0.88
Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity. J Pharmacol Exp Ther (2012) 0.88
Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels. Hypertension (2012) 0.87
Late-phase reaction in ocular allergy. Curr Opin Allergy Clin Immunol (2008) 0.86
Benzofuran derivatives from the mangrove endophytic Fungus Xylaria sp. (#2508). J Nat Prod (2008) 0.85
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation. Vasc Health Risk Manag (2011) 0.83
Exposure to passive smoking: a test to predict endothelial dysfunction and atherosclerotic lesions. Angiology (2008) 0.83
Effect of age on high-fat diet-induced hypertension. Am J Physiol Heart Circ Physiol (2011) 0.82
Effects of Campomanesia xanthocarpa on inflammatory processes, oxidative stress, endothelial dysfunction and lipid biomarkers in hypercholesterolemic individuals. Atherosclerosis (2014) 0.81
Sympathetic cardiac hyperinnervation and atrial autonomic imbalance in diet-induced obesity promote cardiac arrhythmias. Am J Physiol Heart Circ Physiol (2013) 0.80
High fat programming of beta cell compensation, exhaustion, death and dysfunction. Pediatr Diabetes (2014) 0.78
Cardiovascular, metabolic, and coronary dysfunction in high-fat-fed obesity-resistant/prone rats. Obesity (Silver Spring) (2015) 0.78
Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J Clin Endocrinol Metab (2000) 0.78
The oxidation hypothesis of atherosclerosis. Lancet (1994) 0.77
Compensatory hyperinsulinemia in high-fat diet-induced obese mice is associated with enhanced insulin translation in islets. Biochem Biophys Res Commun (2015) 0.76